Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.03 | 0.7 |
mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.7 |
mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.037 | 0.7 |